logo

For the Inventor, By the Inventor

Lille, France

Raphael Darteil

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents. Top assignee: Genfit. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raphael Darteil. Retrieved from https://idiyas.com/inventor/raphael-darteil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 57(Granted Patents)


Company Filing History:

goldMedal14 out of 72 
 
Genfit
 patents

Years Active: 2014-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11103484 - Methods of treatment for cholestatic and fibrotic diseases (2021-08-31),
2. 10905680 - Methods of treatment for cholestatic and fibrotic diseases (2021-02-02),
3. 10722575 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2020-07-28),
4. 10350181 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2019-07-16),
5. 10130613 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-20),
6. 10130612 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-20),
7. 10117856 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-06),
8. 10117855 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-06),
9. 10022343 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2018-07-17),
10. 9782373 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2017-10-10),
11. 9585853 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2017-03-07),
12. 9221751 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2015-12-29),
13. 8895619 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2014-11-25),
14. 8772342 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders (2014-07-08),

Title: The Innovative Contributions of Raphael Darteil

Introduction

Raphael Darteil is a prominent inventor based in Lille, France. He has made significant contributions to the field of medical treatments, particularly focusing on cholestatic and fibrotic diseases. With a total of 14 patents to his name, Darteil's work has the potential to impact many lives.

Latest Patents

Darteil's latest patents include methods of treatment for cholestatic and fibrotic diseases. The inventions relate to the compounds [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) and 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide). These compounds are designed to provide effective treatment options for patients suffering from these challenging conditions.

Career Highlights

Throughout his career, Raphael Darteil has worked with notable companies in the pharmaceutical industry, including Genfit and Enyo Pharma. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Darteil has collaborated with several professionals in his field, including Rémy Hanf and Dean Hum. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…